Pharma.AI - the platform for target discovery, drug design, and clinical trial prediction @InsilicoMedicine
Pharma.AI - the platform for target discovery, drug design, and clinical trial prediction @InsilicoMedicine
Uploaded November 2022 | Updated September 2026, 1 week ago
Alex Aliper, Co-Founder, President, and the Head of our R&D center in Abu Dhabi, talks about the development of Pharma.AI and how we've overcome industry challenges and bias to become a leader in the space of AI-driven therapeutic discovery and de novo small molecule design.
Pharma.AI - the platform for target discovery, drug design, and clinical trial predictionNVIDIA founder and CEO Jensen Huang GTC Keynote on Generative AIPharma.AI Global LaunchRevolutionizing Drug Discovery with AI-Powered InnovationBenchmark DiscoveryAI-powered Drug Discovery lecture by Dr. Michael Levitt, 2013 Nobel Laureate in ChemistryInsilico Medicines first AI-discovered antifibrotic drug goes first-in-humanIntroducing nach0: A one-stop LLM for chemical and biomedical tasksO3DC - Open Drug Discovery and Development Consortium. Hear from the Experts.Insilico Deployed the First Bipedal Humanoid at the AI-Powered Fully-Automated LabIntroduction of PandaOmics for Target Discovery in Amyotrophic Lateral Sclerosis patientsKOLs Interview Series: Dr. Charles Cantor
Insilico Medicine |

Pharma.AI - the platform for target discovery, drug design, and clinical trial prediction

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER